34888 Federal Register / Vol. 87, No. 110 / Wednesday, June 8, 2022 / Notices 

1HRSA. Ryan White HIV/AIDS Program Data 

Report, 2020. 

Information Collection Request Title: 

HIV Quality Measures (HIVQM) Module 

OMB No. 0906–0022—Extension. 

Abstract: The HRSA Ryan White HIV/ 

AIDS Program (RWHAP) funds and 

coordinates with cities, states, and local 

clinics/community-based organizations 

to deliver efficient and effective HIV 

care, treatment, and support to lowincome people with HIV. Since 1990, 

the RWHAP has developed a 

comprehensive system of safety net 

providers who deliver high quality 

direct health care and support services 

to over half a million people with HIV— 

more than 50 percent of all people 

diagnosed with HIV in the United 

States. Nearly two-thirds of clients live 

at or below 100 percent of the federal 

poverty level and approximately threequarters of RWHAP clients are racial/ 

ethnic minorities.1

RWHAP Parts A, B, C, and D 

recipients and sub recipients must 

follow legislative requirements for the 

establishment of clinical quality 

management programs to assess the 

extent to which their HIV services are 

consistent with the most recent 

Department of Health and Human 

Services Clinical Treatment guidelines. 

In support of these requirements, HRSA 

created the HIV Quality Measures 

(HIVQM) Module as an online tool to 

assist recipients in meeting the clinical 

quality management program 

requirement by allowing recipients to 

input data for the HRSA performance 

measures. HRSA maintains over 40 

performance measures across the 

following categories: (1) core, (2) all 

ages, (3) adolescent/adult, (4) HIVinfected children, (5) HIV-exposed 

children, (6) medical case management, 

(7) oral health, (8) AIDS Drug Assistance 

Program, and (9) systems. The HIVQM 

Module also supports the requirement 

imposed by the Uniform Administrative 

Requirements, Cost Principles, and 

Audit Requirements for Health and 

Human Service Award (45 CFR 75.301) 

that recipients relate financial data to 

performance accomplishments of their 

federal awards. The HIVQM Module 

helps recipients set goals and monitor 

performance measures and quality 

improvement projects. The use of the 

HIVQM Module is voluntary for 

RWHAP recipients but strongly 

encouraged. 

Need and Proposed Use of the 

Information: The HIVQM Module 

supports recipients and sub-recipients 

in their clinical quality management 

programs, performance measurement, 

service delivery, and monitoring of 

client health outcomes and quality HIV 

services. The HIVQM Module is 

accessible via the RWHAP Services 

Report, an existing online portal that 

RWHAP recipients use for required data 

collection of their services. Recipients 

may enter performance measures data 

into the HIVQM Module four times a 

year and then generate reports to assess 

their performance. Recipients have the 

option to enter data for specific 

populations for a subset of performance 

measures based on age, gender, race/ 

ethnicity, and risk factor. Recipients 

may also compare their performance 

against other recipients in their state, 

region, and nationally. Additionally, 

recipients can choose the performance 

measures they want to monitor and 

enter data accordingly. For recipients 

and sub-recipients participating in the 

Centers for Medicare & Medicaid 

Incentive Programs, such as the 

Medicare Promoting Interoperability 

Program and the Merit-based Incentive 

Payment System, the HIVQM Module 

may be used to monitor the HRSA 

measures that qualify and comply with 

the requirements to receive incentives 

from these programs. 

Likely Respondents: RWHAP Part A, 

Part B, Part C, and Part D recipients and 

their sub-recipients. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

HIVQM Report ..................................................................... 2,063 4 8,252 1 8,252 

2,063 ........................ 8,252 ........................ 8,252 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–12287 Filed 6–7–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; Post-Award Reporting 

Requirements Including Research 

Performance Progress Report 

Collection (OD) 

AGENCY: National Institutes of Health. 

ACTION: Notice. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 110 / Wednesday, June 8, 2022 / Notices 34889 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, for opportunity 

for public comment on proposed data 

collection projects, the National 

Institutes of Health (NIH) will publish 

periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Ms. Mikia P. Currie, Program 

Analyst, Office of Policy for Extramural 

Research Administration, 6705 

Rockledge Drive, Suite 350, Bethesda, 

Maryland 20892, or call a non-toll-free 

number 301–435–0941 or email your 

request, including your address to 

ProjectClearanceBranch@mail.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Proposed Collection Title: Public 

Health Service (PHS) Post-award 

Reporting Requirements Revision, OMB 

0925–0002, Expiration Date 9/30/2024, 

Office of the Director (OD), National 

Institutes of Health (NIH). 

Need and Use of Information 

Collection: Starting in January 2023, 

NIH will require applicants and 

recipients to submit and address Data 

Management and Sharing Plans within 

the SF424 Research and Related (R&R) 

application and the Research 

Performance Progress Report (RPPR) in 

accordance with the final NIH Policy for 

Data Management and Sharing (DMS 

Policy) to promote the management and 

sharing of scientific data generated from 

NIH-funded or conducted research. The 

application and progress report forms 

will be updated to align with this 

requirement. NIH will also be updating 

the PHS 2271 Statement of 

Appointment form so that trainees 

appointed to institutional Ruth L. 

Kirschstein National Service Research 

Awards (NSRA) can document when 

they receive support for childcare costs. 

The RPPR is required to be used by all 

NIH, Food and Drug Administration, 

Centers for Disease Control and 

Prevention, and Agency for Healthcare 

Research and Quality (AHRQ) grantees. 

Interim progress reports are required to 

continue support of a PHS grant for each 

budget year within a competitive 

segment. The phased transition to the 

RPPR required the maintenance of dual 

reporting processes for a period of time. 

Continued use of the PHS Noncompeting Continuation Progress Report 

(PHS 2590), exists for a small group of 

grantees. This collection also includes 

other PHS post-award reporting 

requirements: PHS 416–7 NRSA 

Termination Notice, PHS 2271 

Statement of Appointment, 6031–1 

NRSA Annual Payback Activities 

Certification, HHS 568 Final Invention 

Statement and Certification, iEdison, 

and PHS 3734 Statement Relinquishing 

Interests and Rights in a PHS Research 

Grant. The PHS 416–7, 2271, and 6031– 

1 is used by NSRA recipients to activate, 

terminate, and provide for payback of a 

NSRA. Closeout of an award requires a 

Final Invention Statement (HHS 568) 

and Final Progress Report. iEdison 

allows grantees and Federal agencies to 

meet statutory requirements for 

reporting inventions and patents. The 

PHS 3734 serves as the official record of 

grantee relinquishment of a PHS award 

when an award is transferred from one 

grantee institution to another. Pre-award 

reporting requirements are 

simultaneously consolidated under 

0925–0001 and the changes to the 

collection here are related. Clinical 

trials are complex and challenging 

research activities. Oversight systems 

and tools are critical for NIH to ensure 

participant safety, data integrity, and 

accountability of the use of public 

funds. NIH has been engaged in a multiyear effort to examine how clinical trials 

are supported and the level of oversight 

needed. The collection of more 

structured information in the PHS 

applications and pre-award reporting 

requirements as well as continued 

monitoring and update during the postaward reporting requirements will 

facilitate NIH’s oversight of clinical 

trials. In addition, some of the data 

reported in the RPPR will ultimately be 

accessible to investigators to update 

certain sections of forms when 

registering or reporting their trials with 

ClinicalTrials.gov. Frequency of 

response: Applicants may submit 

applications for published receipt dates. 

For NSRA awards, fellowships are 

activated, and trainees appointed. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

532,249. 

ESTIMATED ANNUALIZED BURDEN HOURS

Information collection forms Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

REPORTING 

PHS 416–7 ...................................................................................................... 12,580 1 30/60 6,290 

PHS 6031–1 .................................................................................................... 1,778 1 20/60 593

PHS 568 .......................................................................................................... 11,180 1 5/60 932 

iEdison ............................................................................................................. 5,697 1 15/60 1,424 

PHS 2271 ........................................................................................................ 22,035 1 15/60 5,509 

PHS 2590 ........................................................................................................ 243 1 18 4,374 

RPPR—Core Data ........................................................................................... 32,098 1 8 256,784 

Biosketch (Part of RPPR) ................................................................................ 2,544 1 2 5,088 


khammond on DSKJM1Z7X2PROD with NOTICES
34890 Federal Register / Vol. 87, No. 110 / Wednesday, June 8, 2022 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Information collection forms Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Data Tables (Part of RPPR) ............................................................................ 758 1 4 3,032 

Trainee Diversity Report (Part of RPPR) ........................................................ 480 1 15/60 120 

PHS Human Subjects and Clinical Trial Information ....................................... 6,420 1 3 25,680 

Publication Reporting ....................................................................................... 97,023 3 5/60 24,256 

Final RPPR—Core Data .................................................................................. 18,000 1 10 180,000 

Data Tables (Part of Final RPPR) ................................................................... 758 1 4 3,032 

Trainee Diversity Report (Part of Final RPPR) ............................................... 480 1 15/60 120 

PHS Human Subjects and Clinical Trial Information (Part of Final RPPR) .... 3,600 1 4 14,400 

PHS 3734 ................................................................................................. 479 1 30/60 240 

Reporting Burden Total ............................................................................ ........................ ........................ ........................ 531,874 

RECORDKEEPING 

SBIR/STTR Life Cycle Certification ................................................................. 1,500 1 15/60 375 

Grand Total ............................................................................................... ........................ 411,699 ........................ 532,249 

Dated: June 1, 2022. 

Tara A. Schwetz, 

Acting Principal Deputy Director, National 

Institutes of Health. 

[FR Doc. 2022–12279 Filed 6–7–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in Endocrinology and 

Metabolism. 

Date: July 1, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Baskaran Thyagarajan, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 800B, 

Bethesda, MD 20892, (301) 867–5309, 

thyagarajanb2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–20– 

281: Fertility Status as a Marker for Overall 

Health. 

Date: July 12, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Anthony Wing Sang Chan, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 809K, 

Bethesda, MD 20892, (301) 435–5000, 

chana2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Auditory System, Cognition and 

Memory. 

Date: July 12, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Pablo M. Blazquez Gamez, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 435–1042, 

pablo.blazquezgamez@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Innate 

Immunity and Inflammation. 

Date: July 13, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Aftab A. Ansari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4108, 

MSC 7814, Bethesda, MD 20892, (301) 237– 

9931, ansaria@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Infectious Disease and 

Immunology B. 

Date: July 14–15, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Uma Basavanna, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–827–1398, uma.basavanna@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Cancer Immunology and 

Immunotherapy. 

Date: July 14–15, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ola Mae Zack Howard, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7806, Bethesda, MD 20892, 301–451– 

4467, howardz@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Special 

Topics in Biomaterials, Biointerfaces, Gene 

and Drug Delivery. 

Date: July 15, 2022. 

Time: 10:00 a.m. to 9:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 


khammond on DSKJM1Z7X2PROD with NOTICES